Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Cellectis Reports Financial Results for ...||08/06/19|
|NEW YORK-- -- FDA approved IND for UCARTCS1 – first allogeneic CAR T-cell product candidate in multiple myeloma Ongoing construction of in-house manuf...|
|Date||04/12/2019 (AMC)||Est. (EPS/Rev.)||$1.37|
|Actual (EPS/Rev.)||$2.5B||EPS (TTM)||$???|